ACADIA PHARMACEUTICALS INC (ACAD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ACAD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ACAD | Director | 64 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CYTK | 64 | [] | ["Audit Committee"] | 2026 | |
| MDGL | Class I Director | 64 | ["Over 30 years of experience in the biopharmaceutical industry","Executive Vice President and Chief Commercial Officer at Incyte from 2012 until 2015","Various leadership positions at Amgen, Inc. from 2002 to 2011","Over 16 years with Glaxo Wellcome/GlaxoSmithKline","Served on the board of directors of Bellicum Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.","B.S. in Pharmacy and an M.B.A. from the University at Buffalo"] | ["Science and Technology","Nominating and Governance"] | 2026 |
| HALO | ["Medicine and Science", "Pharma Business Leadership and Operations"] | [] | 2023 |
Biography sourced from the proxy statement filing.
of Chimerix Inc., Bellicum Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc. Mr. Daly earned his B.S. in pharmacy and M.B.A. from the University at Buffalo, The State University of New York. The NCG Committee believes that Mr. Daly is qualified to serve as a member of our board of directors based on his extensive experience as an executive and director of life sciences companies.